165 related articles for article (PubMed ID: 33822373)
1. Behavioural and pharmacological effects of cannabidiol (CBD) and the cannabidiol analogue KLS-13019 in mouse models of pain and reinforcement.
Foss JD; Farkas DJ; Huynh LM; Kinney WA; Brenneman DE; Ward SJ
Br J Pharmacol; 2021 Aug; 178(15):3067-3078. PubMed ID: 33822373
[TBL] [Abstract][Full Text] [Related]
2. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice.
Neelakantan H; Tallarida RJ; Reichenbach ZW; Tuma RF; Ward SJ; Walker EA
Behav Pharmacol; 2015 Apr; 26(3):304-14. PubMed ID: 25485642
[TBL] [Abstract][Full Text] [Related]
3. Knockdown siRNA Targeting GPR55 Reveals Significant Differences Between the Anti-inflammatory Actions of KLS-13019 and Cannabidiol.
Brenneman DE; Kinney WA; McDonnell ME; Ippolito MJ; Ward SJ
J Mol Neurosci; 2024 Apr; 74(2):41. PubMed ID: 38602576
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.
Ward SJ; McAllister SD; Kawamura R; Murase R; Neelakantan H; Walker EA
Br J Pharmacol; 2014 Feb; 171(3):636-45. PubMed ID: 24117398
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice.
Ortiz YT; Bilbrey JA; Felix JS; Kienegger EA; Mottinelli M; Mukhopadhyay S; McCurdy CR; McMahon LR; Wilkerson JL
Pharmacol Rep; 2023 Aug; 75(4):937-950. PubMed ID: 37243887
[TBL] [Abstract][Full Text] [Related]
6. Single and combined effects of Δ
King KM; Myers AM; Soroka-Monzo AJ; Tuma RF; Tallarida RJ; Walker EA; Ward SJ
Br J Pharmacol; 2017 Sep; 174(17):2832-2841. PubMed ID: 28548225
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
[TBL] [Abstract][Full Text] [Related]
8. Knockdown siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol.
Brenneman DE; Kinney WA; McDonnell ME; Ippolito MJ; Ward SJ
Res Sq; 2024 Feb; ():. PubMed ID: 38464007
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Comparisons Between Cannabidiol and KLS-13019.
Brenneman DE; Petkanas D; Kinney WA
J Mol Neurosci; 2018 Sep; 66(1):121-134. PubMed ID: 30109468
[TBL] [Abstract][Full Text] [Related]
10. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity.
Brenneman DE; Kinney WA; Ward SJ
J Mol Neurosci; 2019 Aug; 68(4):603-619. PubMed ID: 31077084
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model.
Jesus CHA; Ferreira MV; Gasparin AT; Rosa ES; Genaro K; Crippa JAS; Chichorro JG; Cunha JMD
Behav Brain Res; 2022 Oct; 435():114076. PubMed ID: 36028000
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
Rodríguez-Muñoz M; Onetti Y; Cortés-Montero E; Garzón J; Sánchez-Blázquez P
Mol Brain; 2018 Sep; 11(1):51. PubMed ID: 30223868
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
Crivelaro do Nascimento G; Ferrari DP; Guimaraes FS; Del Bel EA; Bortolanza M; Ferreira-Junior NC
Neuropharmacology; 2020 Feb; 163():107808. PubMed ID: 31706993
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antiallodynic Activity of Cannabidiol Analogue on Peripheral Neuropathy in Mice.
Marques GVL; Braga AV; Silva IR; de Souza ARB; Kohlhoff M; César IC; Machado RR; Oliveira RB
Chem Biodivers; 2024 Apr; 21(4):e202301935. PubMed ID: 38363210
[TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties.
Harris HM; Gul W; ElSohly MA; Sufka KJ
Cannabis Cannabinoid Res; 2022 Dec; 7(6):804-813. PubMed ID: 34962133
[No Abstract] [Full Text] [Related]
16. Cannabidiol reduces ethanol consumption, motivation and relapse in mice.
Viudez-Martínez A; García-Gutiérrez MS; Navarrón CM; Morales-Calero MI; Navarrete F; Torres-Suárez AI; Manzanares J
Addict Biol; 2018 Jan; 23(1):154-164. PubMed ID: 28194850
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice.
Sepulveda DE; Morris DP; Raup-Konsavage WM; Sun D; Vrana KE; Graziane NM
Cannabis Cannabinoid Res; 2022 Oct; 7(5):648-657. PubMed ID: 34846928
[No Abstract] [Full Text] [Related]
18. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
19. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
